S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial

被引：0

作者：

Shi, Yuankai ^{[1
,2
]}

Wang, Mengzhao ^{[3
]}

He, Jianxing ^{[4
]}

Chang, Jianhua ^{[5
]}

Han, Baohui ^{[6
]}

Liu, Xiaoqing ^{[7
]}

Chen, Gongyan ^{[8
]}

Zhou, Caicun ^{[9
]}

Liu, Jiwei ^{[10
]}

Pan, Hongming ^{[11
]}

Huang, Cheng ^{[12
]}

Zhang, Shucai ^{[13
]}

Feng, Jifeng ^{[14
]}

Lin, Xiaoyan ^{[15
]}

Wang, Jie ^{[16
]}

Huang, Jianjin ^{[17
]}

Li, Fang ^{[18
]}

Qin, Shukui ^{[19
]}

Wang, Zhehai ^{[20
]}

Wang, Liwei ^{[21
]}

Xu, Nong ^{[22
]}

机构：

[1] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing 100730, Peoples R China

[2] Peking Union Med Coll, Natl Ctr Anticanc Drugs Clin Study, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing 100021, Peoples R China

[3] Beijing Union Med Coll Hosp, Beijing, Peoples R China

[4] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China

[5] Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China

[6] Shanghai Chest Hosp, Shanghai, Peoples R China

[7] Acad Mil Med Sci, Affiliated Hosp, Beijing, Peoples R China

[8] Harbin Med Univ, Affiliated Tumor Hosp, Harbin, Peoples R China

[9] Shanghai Pulm Hosp, Shanghai, Peoples R China

[10] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China

[11] Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China

[12] Fujian Prov Tumor Hosp, Fuzhou, Peoples R China

[13] Beijing Chest Hosp, Beijing, Peoples R China

[14] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China

[15] Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China

[16] Beijing Canc Hosp, Beijing, Peoples R China

[17] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China

[18] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China

[19] 81 Hosp PeopleS Liberat Army, Nanjing, Peoples R China

[20] Shandong Canc Hosp, Jinan, Peoples R China

[21] Shanghai First PeopleS Hosp, Shanghai, Peoples R China

[22] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

S-1; phase; 3; trial; Therapy; NSCLC;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

ORAL01.06

引用

页码：S174 / S174

页数：1

共 50 条

[1] Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial
Yamada, Yasuhide
Boku, Narikazu
Mizusawa, Junki
Iwasa, Satoru
Kadowaki, Shigenori
Nakayama, Norisuke
Azuma, Mizutomo
Sakamoto, Takeshi
Shitara, Kohei
Tamura, Takao
Chin, Keisho
Hata, Hiroaki
Nakamori, Mikihito
Hara, Hiroki
Yasui, Hirofumi
Katayama, Hiroshi
Fukuda, Haruhiko
Yoshikawa, Takaki
Sasako, Mitsuru
Terashima, Masanori
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (07): : 501 - 510
[2] Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma
Ajani, JA
Lec, FC
Singh, DA
Haller, DG
Lenz, HJ
Benson, AB
Yanagilhara, R
Phan, AT
Yao, JC
Strumberg, D
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (04) : 663 - 667
[3] An open-label, randomized, multicenter, phase III study of S-1 and cisplatin versus docetaxel and cisplatin in patients with untreated advanced non-small-cell lung cancer.
He, Jianxing
Shi, Yuankai
Chang, Jianhua
Wang, Mengzhao
Han, Baohui
Liu, Xiaoqing
Chen, Gongyan
Zhou, Caicun
Liu, Jiwei
Pan, Hongming
Huang, Cheng
Zhang, Shucai
Feng, Jifeng
Lin, Xiaoyan
Wang, Jie
Huang, Jianjin
Li, Fang
Qin, Shukui
Wang, Zhehai
Wang, Liwei
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[4] A randomised phase II trial of capecitabine plus cisplatin versus S-1 plus cisplatin as a first-line treatment for advanced gastric cancer: Capecitabine plus cisplatin ascertainment versus S-1 plus cisplatin randomised PII trial (XParTS II)
Nishikawa, Kazuhiro
Tsuburaya, Akira
Yoshikawa, Takaki
Kobayashi, Michiya
Kawada, Junji
Fukushima, Ryoji
Matsui, Takanori
Tanabe, Kazuaki
Yamaguchi, Kazuya
Yoshino, Shigefumi
Takahashi, Masazumi
Hirabayashi, Naoki
Sato, Seiji
Nemoto, Hiroshi
Rino, Yasushi
Nakajima, Junta
Aoyama, Toru
Miyagi, Yohei
Oriuchi, Noboru
Yamaguchi, Kensei
Miyashita, Yumi
Morita, Satoshi
Sakamoto, Junichi
EUROPEAN JOURNAL OF CANCER, 2018, 101 : 220 - 228
[5] Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in patients with advanced biliary tract adenocarcinoma
Kang, Myoung Joo
Lee, Jae-Lyun
Kim, Tae Won
Lee, Sung Sook
Ahn, Shin
Park, Do Hyun
Lee, Sang Soo
Seo, Dong Wan
Lee, Sung Koo
Kim, Myung-Hwan
ACTA ONCOLOGICA, 2012, 51 (07) : 860 - 866
[6] Phase I Study of Docetaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer
Hironaka, Shuichi
Yamazaki, Kentaro
Taku, Keisei
Yokota, Tomoya
Shitara, Kohei
Kojima, Takashi
Ueda, Shinya
Machida, Nozomu
Muro, Kei
Boku, Narikazu
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (11) : 1014 - 1020
[7] Randomized phase II trial of S-1 and cisplatin versus gemeitabine and cisplatin in advanced biliary tract adenocarcinoma
Kang, M.
Lee, J.
Kim, T.
Lee, S.
Park, D.
Seo, D.
Kim, M.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[8] Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
Koizumi, W.
Yamaguchi, K.
Hosaka, H.
Takinishi, Y.
Nakayama, N.
Hara, T.
Muro, K.
Baba, H.
Sasaki, Y.
Nishina, T.
Fuse, N.
Esaki, T.
Takagi, M.
Gotoh, M.
Sasaki, T.
BRITISH JOURNAL OF CANCER, 2013, 109 (08) : 2079 - 2086
[9] Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancer
W Koizumi
K Yamaguchi
H Hosaka
Y Takinishi
N Nakayama
T Hara
K Muro
H Baba
Y Sasaki
T Nishina
N Fuse
T Esaki
M Takagi
M Gotoh
T Sasaki
British Journal of Cancer, 2013, 109 : 2079 - 2086
[10] A randomized phase II trial of docetaxel plus S-1 versus docetaxel plus cisplatin in advanced gastric cancer as a first-line treatment
Jeung, H.
Im, C.
Rha, S.
Ahn, J.
Shin, S.
Noh, S.
Roh, J.
Chung, H.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →